Page last updated: 2024-08-22

sodium arsenite and Acute Lymphoid Leukemia

sodium arsenite has been researched along with Acute Lymphoid Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, I; Kim, S; Koh, Y; Liu, Y; Oh, S; Shin, DY1
Centeno, F; Coleman, MA; Córdova, EJ; Koneru, H; Martínez-Hernández, A; Morales-Marín, M; Orozco, L; Uribe-Figueroa, L1

Other Studies

2 other study(ies) available for sodium arsenite and Acute Lymphoid Leukemia

ArticleYear
KML001 and doxercalciferol induce synergistic antileukemic effect in acute lymphoid leukemia cells.
    Oncology reports, 2017, Volume: 38, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenites; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Ergocalciferols; G2 Phase Cell Cycle Checkpoints; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sodium Compounds

2017
The NRF2-KEAP1 pathway is an early responsive gene network in arsenic exposed lymphoblastoid cells.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Apoptosis; Arsenites; Cell Line, Tumor; Gene Expression; Gene Regulatory Networks; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; NF-E2-Related Factor 2; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; Sodium Compounds

2014